305 related articles for article (PubMed ID: 10594354)
1. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
Trebak M; Chong JM; Herlyn D; Speicher DW
J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
[TBL] [Abstract][Full Text] [Related]
2. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
Bruce MP; Boyd V; Duch C; White JR
J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
[TBL] [Abstract][Full Text] [Related]
3. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
[TBL] [Abstract][Full Text] [Related]
4. Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells.
Aybay C; Imir T
J Immunol Methods; 2000 Jan; 233(1-2):77-81. PubMed ID: 10648858
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric analyses of hybridoma growth on glass cylinders in a packed-bed bioreactor system with internal aeration. Serum-supplemented and serum-free media comparison for MAb production.
Moro AM; Rodrigues MT; Gouvea MN; Silvestri ML; Kalil JE; Raw I
J Immunol Methods; 1994 Nov; 176(1):67-77. PubMed ID: 7963595
[TBL] [Abstract][Full Text] [Related]
6. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
Nagel A; Koch S; Valley U; Emmrich F; Marx U
Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
[TBL] [Abstract][Full Text] [Related]
7. Growth of hybridoma cells and antibody production in agamma calf serum.
Torres AR; Healey MC; Johnston AV; McKnight ME
Hum Antibodies Hybridomas; 1992 Oct; 3(4):206-11. PubMed ID: 1477302
[TBL] [Abstract][Full Text] [Related]
8. Serum preparation and methods for the large-scale production of IgG monoclonal antibody.
Zeng QS; Takeyama H; Kanda S; Irie RF
Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185
[TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal antibodies in dialysis tubing.
Sjögren-Jansson E; Ohlin M; Borrebaeck CA; Jeansson S
Hybridoma; 1991 Jun; 10(3):411-9. PubMed ID: 1916852
[TBL] [Abstract][Full Text] [Related]
10. Bovine colostrum ultrafiltrate: an effective supplement for the culture of mouse-mouse hybridoma cells.
Pakkanen R; Neutra M
J Immunol Methods; 1994 Feb; 169(1):63-71. PubMed ID: 8133074
[TBL] [Abstract][Full Text] [Related]
11. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
[TBL] [Abstract][Full Text] [Related]
12. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
[TBL] [Abstract][Full Text] [Related]
13. Production of monoclonal antibodies in culture.
Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium.
Schneider YJ
J Immunol Methods; 1989 Jan; 116(1):65-77. PubMed ID: 2644356
[TBL] [Abstract][Full Text] [Related]
15. Long-term production of human monoclonal antibodies by five human-mouse heterohybridomas in a serum-free medium.
Yoshinari K; Matsumoto K
Hybridoma; 1998 Oct; 17(5):479-85. PubMed ID: 9873994
[TBL] [Abstract][Full Text] [Related]
16. A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma.
Yang ST; Luo J; Chen C
Adv Biochem Eng Biotechnol; 2004; 87():61-96. PubMed ID: 15217104
[TBL] [Abstract][Full Text] [Related]
17. Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers.
Voigt A; Zintl F
J Biotechnol; 1999 Feb; 68(2-3):213-26. PubMed ID: 10194858
[TBL] [Abstract][Full Text] [Related]
18. Considerations for in vitro monoclonal antibody production.
Peterson NC
Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417
[No Abstract] [Full Text] [Related]
19. Monitoring of the production of monoclonal antibodies by hybridomas. Part I: Long-term cultivation in hollow fibre bioreactors using serum-free medium.
van Erp R; Adorf M; van Sommeren AP; Schönherr OT; Gribnau TC
J Biotechnol; 1991 Oct; 20(3):235-48. PubMed ID: 1367571
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
Kundu PK; Prasad NS; Datta D
Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
